Financhill
Back

TG Therapeutics Stock Predictions

TG Therapeutics Stock Forecast

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 18.3% based on the past 28 years of stock performance.
  • TG Therapeutics has risen higher in 12 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
  • Is TG Therapeutics Stock Undervalued?
    The current TG Therapeutics [TGTX] share price is $37.67. The Score for TGTX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • TGTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will TG Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 18.3% based on the past 28 years of stock performance.

TG Therapeutics Stock Rating

Buy
59
TG Therapeutics (TGTX) is a Buy

Is TG Therapeutics overpriced?

  • TG Therapeutics has risen higher in 12 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%

TG Therapeutics Stock Price History

Is TGTX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TGTX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tgtherapeutics.com

52-Week Data

52-Week High:
46.48
52-Week Low:
16.65

Prediction Charts

Market Cap:
6B
Price in USD:
37.67
Volume:
1.3M
Beta:
0.92

Technical Analysis

SMA50:
36.72
SMA100:
36.83
SMA200:
32.84
52-Wk Change:
83.76%

Stock Predictions

  • Is TG Therapeutics stock public?
    Yes, TG Therapeutics is a publicly traded company.
  • What is the TG Therapeutics stock quote today?
    The TG Therapeutics stock price is 37.67 USD today.
  • How to buy TG Therapeutics stock online?
    You can buy TG Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-20 35.52 36.04 36.31 35.20
Jun-23 36.20 36.56 36.58 35.18
Jun-24 37.00 37.30 37.58 36.31
Jun-25 37.40 37.26 37.49 36.37
Jun-26 37.36 37.95 37.98 36.86
Jun-27 37.95 36.71 38.08 36.50
Jun-30 36.85 35.97 37.22 35.74
Jul-1 35.77 35.40 36.91 35.10
Jul-2 35.27 36.29 36.35 35.03
Jul-3 36.36 36.72 36.96 36.07
Jul-7 36.60 35.98 36.91 35.52
Jul-8 36.09 35.61 36.48 34.36
Jul-9 35.99 37.92 37.94 35.43
Jul-10 37.57 37.67 38.39 37.38

TG Therapeutics Earnings

TG Therapeutics Earnings Report: Per Share TG Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

TG Therapeutics Forecast Revenue Growth

TG Therapeutics Stock Analysis: Historical quarterly revenues per share for TG Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.19 per share, an increase this year of $0.75 per share, and an increase next year of $0.86 per share.

* TG Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.